Fortress Biotech Patents – Insights & Stats (Updated 2023)

Fortress Biotech has a total of 130 patents globally, out of which 88 have been granted. Of these 130 patents, more than 78% patents are active. The United States of America is where Fortress Biotech has filed the maximum number of patents, followed by Canada and Australia. Parallelly, The United States of America seems to be the main focused R&D center and also USA is the origin country of Fortress Biotech. Fortress Biotech was founded in 2006. The Company is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products. The Company will provide funding and management services to each of the Fortress Companies, and will seek licensing, partnerships, joint ventures and/or public and private financing for research and development support. Do read about some of the most popular patents of Fortress Biotech which have been covered by us in this article and also you can find Fortress Biotech patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Fortress Biotech patent portfolio.

How many patents does the Founder and CEO of Fortress Biotech have?

The Founder and the CEO Lindsay Rosenwald has 4 patents.

How many patents does Fortress Biotech have?

Fortress Biotech has a total of 130 patents globally. These patents belong to 26 unique patent families. Out of 130 patents, 102 patents are active.

How Many Patents did Fortress Biotech File Every Year?

Fortress Biotech Patent Filing Trend Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant Fortress Biotech Applications Filed Fortress Biotech Patents Granted
2023 2
2022 7 16
2021 11 6
2020 14 14
2019 10 13
2018 14 10
2017 17 8
2016 4 4
2015 14 6
2014 13 3
2013 7 5
2012 2 1
 

How many Fortress Biotech patents are Alive/Dead?

Worldwide Patents Fortress Biotech Patent Portfolio

How Many Patents did Fortress Biotech File in Different Countries?

Fortress Biotech Worldwide Patent Filing

Countries in which Fortress Biotech Filed Patents

Country Patents
United States Of America 72
Canada 13
Australia 6
Japan 6
Europe 6
Germany 4
South Africa 3
Austria 3
Singapore 2
New Zealand 2
Hong Kong (S.A.R.) 2
China 1
Mexico 1
Italy 1
United Kingdom 1

Where are Research Centers of Fortress Biotech Patents Located?

R&D Centers of Fortress Biotech

 10 Best Fortress Biotech Patents

US8343945B2 is the most popular patent in the Fortress Biotech portfolio. It has received 130 citations so far from companies like Foamix Ltd., Sanyo Electric Co., Ltd. and Novan, Inc.

Below is the list of 10 most cited patents of Fortress Biotech:

Publication Number Citation Count
US8343945B2 130
US8518376B2 119
US8618081B2 73
US8900553B2 60
US9161916B2 59
US8871184B2 55
US8992896B2 48
US9549898B2 43
US8945516B2 41
US9675700B2 35

How many inventions of other companies were rejected due to Fortress Biotech patents?

The statistics below share strategic R&D insights. It tells the companies that were trying to protect inventions similar to Fortress Biotech invention. They couldn’t because Fortress Biotech had protected those before them. Examiners at the USPTO referred 19 Fortress Biotech patents in 86 rejections (35 USC § 102 or 35 USC § 103 types). The top citing companies in the Fortress Biotech patent portfolio are Journey Medical Corporation, Global Health Solutions and Vyne Pharmaceuticals. List of the Companies whose Patents were rejected citing Fortress Biotech –
Company Number of Patent Applications that faced Rejection Citing Fortress Biotech Patents Number of Rejections (102 & 103)
Journey Medical Corporation 10 28
Global Health Solutions 3 3
Vyne Pharmaceuticals 2 8
Nissan Chemical Corporation 1 4
Universite Claude Bernard 1 1
Paul Hartmann 1 4
Dermira 1 2
Botanix Pharmaceuticals 1 2
Foamix 1 2
Padagis Israel Pharmaceuticals 1 1

Count of 102 and 103 Type Rejections based on Fortress Biotech Patents

Top Fortress Biotech Patents used in Rejecting Most Patent Applications

Patent Number Count of Rejected Applications
US8945516B2 6
US8343945B2 6
US8618081B2 4
US9549898B2 4
US8518376B2 4
US8558008B2 4
US10029013B2 3
US8871184B2 3
US8900553B2 2
US9675700B2 1
US9440056B2 1
US9884017B2 1
US10398641B2 1
US10590199B2 1
US10265404B2 1

What Percentage of Fortress Biotech US Patent Applications were Granted?

Fortress Biotech (Excluding its subsidiaries) has filed 3 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 2 have been granted leading to a grant rate of 100.0%. Below are the key stats of Fortress Biotech patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Fortress Biotech?

Law Firm Total Applications Success Rate
Dla Piper 2 100.00%
Foley & Lardner 1 100.00%

What are Fortress Biotech key innovation segments?

What Technologies are Covered by Fortress Biotech?

The chart below distributes patents filed by Fortress Biotech in different countries on the basis of the technology protected in patents. It also represents the markets where Fortress Biotech thinks it’s important to protect particular technology inventions.

R&D Focus: How has Fortress Biotech search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Fortress Biotech?

Related Articles

VoxelSensors Patents – Insights & Stats (Updated 2024)

VoxelSensors has a total of 36 patents globally, out of which 8 have been granted. Of these 36 patents, more than 94% patents are active. Europe (EPO) is where VoxelSensors has filed the maximum number of patents, followed by China and Israel. Parallelly, Belgium seems to be the main focused

Read More »

Alphapharm Patents – Insights & Stats (Updated 2024)

Alphapharm has a total of 108 patents globally, out of which 43 have been granted. Of these 108 patents, more than 18% patents are active. Australia is where Alphapharm has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, Australia seems to be

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.